[Treatment of asthma in Poland by primary care physicians--results of PulmoScreen study]

Wiad Lek. 2013;66(2 Pt 2):139-44.
[Article in Polish]

Abstract

Introduction: Proper treatment of asthma patients is crucial for long-term control of the disease.

Objective: The aim of the study was to evaluate the treatment of adult asthma patients by primary care physicians in the light of international GINA guidelines.

Material and method: The cross-sectional study included a representative sample of 1852 general practitioners (GPs) who were asked to complete questionnaires on the diagnosis and treatment often consecutive patients with asthma who are under their care.

Results: Altogether 1250 GPs provided information about 10,981patients. During the entire duration of the disease 50.9% were ever treated by systemic corticosteroids. In the current treatment of asthma inhaled steroids were used in 78.8% of cases, oral steroids in 5.8%, intravenous steroids in 1.3% and intramuscular steroids in 0.7% of patients. SABA were used in 63.1% of patients, LABA in 57.1%, methylxanthine in 25.1%, leukotriene modifiers in 21.1%, anticholinergics drugs in 15.5%, cromones in 1,9%, and antihistamines in 23.1% of adult patients with asthma. In 88.8% cases LABA treatment was combined with inhaled corticosteroids. In 83.8% of cases therapeutic regimens were in line with the GINA guidelines.

Conclusions: There is a need for systematic educational activities addressed to primary care physicians.

Publication types

  • English Abstract

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Ambulatory Care / statistics & numerical data*
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / diagnosis
  • Asthma / drug therapy*
  • Asthma / epidemiology*
  • Cross-Sectional Studies
  • General Practitioners / statistics & numerical data*
  • Health Status
  • Humans
  • Leukotriene Antagonists / therapeutic use
  • Poland / epidemiology
  • Primary Health Care / statistics & numerical data*
  • Professional-Patient Relations
  • Severity of Illness Index

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-Antagonists
  • Anti-Asthmatic Agents
  • Leukotriene Antagonists